Veronica Mijares

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis.

Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis.

Journal: Scientific reports
Published: December 23, 2019

Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis.

Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis.

Journal: Clinical and experimental rheumatology
Published: November 07, 2019

Influence of MUC5B gene on antisynthetase syndrome.

Influence of MUC5B gene on antisynthetase syndrome.

Journal: Scientific reports
Published: September 11, 2019

Association of circulating calprotectin with lipid profile in axial spondyloarthritis.

Association of circulating calprotectin with lipid profile in axial spondyloarthritis.

Journal: Scientific reports
Published: July 19, 2018

Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.

Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 28, 2018

Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis.

Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis.

Journal: Scientific reports
Published: May 12, 2017

Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.

Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.

Journal: The Journal of dermatological treatment
Published: May 11, 2017

Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients.

Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients.

Journal: Clinical and experimental rheumatology
Published: May 02, 2017

A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.

A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.

Journal: Scientific reports
Published: January 26, 2017

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

Journal: Scientific reports
Published: October 20, 2016

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

Journal: Scientific reports
Published: May 16, 2016

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.

Journal: Scientific reports
Published: February 18, 2016
Showing 1-12 of 25

Last Updated: 09/26/2026